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Abstract. Background/Aim: Despite the large amount of
clinical data available of Coronavirus-19 (COVID-19), not
many studies have been conducted about the psychological
toll on Health Care Workers (HCWs). Patients and Methods:
In this multicentric descriptive study, surveys were
distributed among 4 different Breast Cancer Centers (BCC).
BCCs were distinguished according to COVID-19 tertiary
care hospital (COVID/No-COVID) and district prevalence
(DP) (High vs. Low). DASS-21 score, PSS score and
demographic data (age, sex, work) were evaluated. Results:
A total of 51 HCWs were analyzed in the study. Age, work
and sex did not demonstrate statistically significant values.
Statistically significant distribution was found between
DASS-21-stress score and COVID/No-COVID (p=0.043). No
difference was found in the remaining DASS-21 and PSS
scores, dividing the HCWs according to COVID-19-hospital
and DP. Conclusion: Working in a COVID-19-hospital
represents a factor that negatively affects psychosocial well-
being. However, DP seems not to affect the psychosocial
well-being of BCC HCWs. During the outbreak,
psychological support for low risk HCWs should be provided
regardless DP. 
The first case of atypical pneumonia previously named as
Severe Acute Respiratory Syndrome Corona Virus 2
(COVID-19) was recorded in December 2019 in China. Italy
has been the first European country to be involved in this
outbreak. The national health care system (NHS) is currently
reallocating resources from elective and semi-elective
patients toward severe COVID-19 patients (1, 2). Italy has
exceeded the cases recorded in China and unfortunately, up
to now (May, 17th), 225,435 cases and 31908 deaths have
been registered with still over 700 admitted to intensive care
units (3). The Italian outbreak is mainly located in clusters
along the north of Italy (Lombardia, Veneto and Emilia
Romagna) and a low incidence in central and southern
regions (1, 3, 4). 
In order to control COVID-19, resource reallocation
eventually led to the creation of hospitals partially or totally
dedicated to COVID-19 patients (COVID-hospital), therefore
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increasing numbers of health care workers (HCWs) have
been facing a new highly contagious infectious disease (5).
In spite of having a separate route and applying infection
control (IC) measures during this period, patients could
refuse surgery or diagnostic procedures due to COVID-19
infection risk, reducing the number of admitted patients in
the hospital (2, 6-8). Moreover, IC measures include
instructions to HCWs to maintain a physical distance from
other colleagues, patients and families which could
eventually lead to psychological distress (9-11). Previous
studies that took place during the Toronto SARS outbreak
have shown that many HCWs presented high levels of
psychological distress who were mostly concerned about
infecting family and friends as well as about the disease
consequences on their own health. Worries about their
functional ability and fear of stigmatization along with social
isolation and higher job stress have been described (9-11).
Many studies showed HCWs who are in the front line of the
diagnosis, treatment and care of patients with an emerging
disease like COVID-19, are more frequently at risk of
developing psychological distress and mental health
disorders (12-15). Other causes of HCWs' psychological
distress were strenuous workload, depletion of personal
protective equipment, lack of specific drugs and the
uncertainty of dealing with an illness whose transmissibility
is partially understood (15).
Despite the great deal of existing literature regarding
psychological distress in the high-risk area, little is known
about the psychological distress among HCWs at low risk
and the impact of the outbreak on HCWs who aren’t directly
involved in COVID-19 treatment. The present study aimed
to assess differences in the degree of depression, anxiety and
distress among different Italian Breast Cancer Centers
(BCCs) HCWs according to COVID hospital/No-COVID
hospital and prevalence of the disease in the hospital district
(high prevalence vs. low prevalence).
Patients and Methods 
Study design. The study was designed as multicentric and
descriptive. The institutional review board of Policlinico Tor Vergata
waived the need for a formal approval. Due to the difference in
COVID-19 prevalence (4) and national breast screening programs
across Italy (13, 14), we included 4 different BCCs across Italy:
Azienda Ospedaliero-Universitaria Policlinico Hospital of Modena,
Campus Bio-Medico University Hospital of Rome, "Guglielmo da
Saliceto" Hospital Piacenza and Policlinico Tor Vergata University
Hospital. BCCs and Hospital were divided as shown in Table I.
COVID-19 hospital was defined as the hospital that was totally or
partially designated by the NHS as tertiary care institutions for
COVID-19 disease. 
Population. All HCWs from 4 Italian BCCs were invited to
complete written questionnaires between April 1st and April 30th; 51
forms were collected. The main inclusion criteria were work in
tertiary BCCs and no involvement with COVID-19 patients. All
participants were allowed to terminate the survey at any time they
wished. The population was subdivided for analysis according to
demographic data, prevalence (high prevalence vs. low prevalence)
and COVID hospital (COVID vs. No-COVID hospital). HCWs’
roles were recorded and divided between physician, surgeon, nurse. 
Questionnaires and score. An e-mail was sent to each breast cancer
unit manager, informing about the study and asking for their
permission to distribute the questionnaires among their employees.
Blank anonymous questionnaires were placed at various designated
work areas in each participating unit during the study period. All
questionnaires were collected by personnel not involved in the study
analysis from each BCC and were sent to Tor Vergata for analysis. 
To assess HCW’s worries and concerns over the pandemic, their
behavior during the outbreak and whether these factors were related
to psychological distress and other mental health symptoms like
depression, anxiety and stress, the following two self-reported
questionnaires were administered: the depression, anxiety and stress
scale (DASS-21) and the perceived stress scale (PSS) by Sheldon
Cohen. The first part of both questionnaires’ inquiries about basic
demographic data (age, sex, occupation and workplace). 
The depression, anxiety and stress scale – 21 items (DASS-21) is
a set of three self-report scales designated to measure the emotional
states of depression, anxiety and stress. Each of the three DASS-21
scales contains 7 items, divided into subscales with similar content.
Participants were asked to respond according to how closely the item
applied to them in the period of the outbreak. The scale uses the
Likert four-level scoring system, with 0 to 3 points representing non-
conformity (0) to very consistent (3). Higher scores are linked with
higher level of negative emotions (14).
The total scores of these measurement tools were interpreted as
follows: Depression, normal [0-9], mild [10-13], moderate [14-20],
severe [21-27], extremely severe (28+); Anxiety, normal [0-7], mild
[8-9], moderate [10-14], severe [15-19], extremely severe [20+];
Stress, normal [0-14], mild [15-18], moderate [19-25], severe [26-
33], extremely severe [34+].
The 10-item Perceived Stress Scale (PSS) by Sheldon Cohen (16)
is the most widely used psychological instrument for measuring
global perceived stress and is a robust predictor of health and
disease (13, 17). The scale measures global perceived stress
in vivo 34: 1685-1694 (2020)
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Table I. Distribution of Breast Centre according to COVID-19 prevalence and COVID-hospital designation.
                                                                       Low prevalence                                                                               High prevalence
COVID Hospital                     Policlinico Tor Vergata University Hospital                                   "Guglielmo da Saliceto" Hospital Piacenza
No-COVID Hospital         Campus Bio-Medico University Hospital of Rome         Azienda Ospedaliero-Universitaria Policlinico Hospital of Modena
experienced across the past 30 days on a 5-point scale: never [0],
almost never [1], once in a while [2], often [3], very often [4]. Total
scores range from 0 to 40. Total PSS score is classified as: 0-13 low
perceived stress, 14-26 medium perceived stress, 27-40 high
perceived stress.
Statistical analysis. All data were submitted into the EXCEL
datasheet (Microsoft, Washington, DC, USA). DASS-21 and PSS-
10 scores were analyzed as continuous variables and ordinal
variables according to the respective classification. Due to the small
sample size, all continues variables are expressed as a median and
an interquartile range (IQR). t-test and ANOVA were used to
determine the p-value for continuous variables. When DASS-21
score was treated as dummy variable, independent-samples Kruskal-
Wallis test or Independent-Samples Mann-Whitney U-test were used
to determine the p-value for nominal data or dichotomous variables,
respectively. Pearson’s coefficient was used to assess any correlation
between continuous variables and PSS-10 and DASS-21 scores.
Categorical data were recoded as numbers and percentages. Analysis
was performed using the Fisher’s exact test for dichotomous
variable. All the statistical analyses were performed in SPSS
statistical package version 23.0 (SPSS Inc., Chicago, IL, USA). 
Results 
Demographic data. A total of 51 HCWs answered to the
survey, 5 HCWs were excluded from the study as they didn’t
complete the demographic data or both tests (PSS-10 or
DASS-21). Thus, the population consisted of 46 HCWs from
the 4 different hospitals. 65.22% of the HCWs who answered
the survey were females. 78.26% were medical doctors and
the remaining nurses (21.74%). HCWs’ population was
subsequently divided according to COVID/NO-COVD and
prevalence. Twenty-nine (63%) of the surveyed population
worked in COVID hospital and 17 (37%) in No-COVID
hospital. Grouping by districts, 27 HCWs (58.70%) worked
in low prevalence areas and 19 (41.30%) in high prevalence
districts (Table II). 
In the general population, DASS-21 score revealed a
median value of 16, 5, and 6 regarding stress, anxiety and
depression, respectively. 71.74% of HCWs experienced mild
to extremely severe stress level according to DASS-21 score.
32.6% HCWs experienced anxiousness and 36.95%
depression symptoms. Median PSS score was 16.5. Table III
summarizes calculations of linear regression between DASS-
21 and PSS-10 scores with age, showing no correlations (R:
0.0217, -0.033, 0.2424, 0.1853 for DASS-21 Stress, DASS-
21 Anxiety, DASS-21 depression and PSS-10, respectively).
Subdivision of the population according to sex exhibited
no difference in terms of median DASS-21 stress, anxiety
and depression values. Moreover, PSS scores demonstrated
casual distribution between ages (Table IV). 
Analyzing data regarding Profession and DASS-21 or PSS
score value showed no statistical significance. Population
grouping according to the level of symptoms (normal, mild,
moderate, severe, extremely severe for DAS-21 score and low,
medium and high perceived stress) didn’t show any statistical
difference in stress, anxiety and depression or perceived stress
level among nurses, physicians and surgeons (Table V). 
Vanni et al: Effect of COVID-19 on Breast Cancer Teamwork
1687
Table II. Demographic characteristics, Mean DASS-21 and PSS score,
Subdivision according DASS-21 and PSS score subdivision. Categorical
variables are expressed as numbers and percentages, continuous
variables are expressed as a median and an IQR (interquartile range). 
Demographics
   
Age [median (IQR)]                                                   47 (40-54) yr 
Female gender, N (%)                                             30/46 (65.22%)
Prevalence distribution                                                          
   Low prevalence N (%)                                         27/46 (58.70%)
   High prevalence N (%)                                         19/46 (41.30%)
COVID Hospital                                                                    
   NO COVID Hospital N (%)                                 17/46 (37.00%)
   COVID Hospital N (%)                                        29/46 (63.00%)
Profession, N (%)                                                                  
   Nurse                                                                     10/46 (21.73%)
   Physician                                                               18/46 (39.13%)
   Surgeon                                                                 18/46 (39.13%)
DASS-21 Score                                                                     
   Stress [median (IQR)]                                             16 (10-21.5)
   Anxiety [median (IQR)]                                          5 (2.5-11.5)
   Depression [median (IQR)]                                      6 (4-13.5)
Stress N (%)                                                                          
   Normal                                                                   13/46 (28.26%)
   Mild to moderate                                                  27/46 (58.70%)
   Severe to extremely severe                                   6/46 (13.04%)
Anxiety N (%)                                                                       
   Normal                                                                   28/46 (60.87%)
   Mild to moderate                                                  12/46 (19.56%)
   Severe to extremely severe                                   6/46 (13.04%)
Depression N (%)                                                                  
   Normal                                                                   29/46 (63.04%)
   Mild to moderate                                                   9/46 (19.56%)
   Severe to extremely severe                                   8/46 (17.39%)
PSS Score                                                                              
   PSS score [median (IQR)]                                    16.5 (11.25-21)
PSS Score                                                                              
   Low perceived stress N (%)                                 15/46 (32.61%)
   Medium perceived stress N (%)                          26/46 (56.52%)
   High perceived stress N (%)                                 5/46 (10.87%)  
Table III. Linear correlation and DASS-21 and PSS scores. All Values
are reported as a median and an IQR in the brackets. IQR: Interquartile
range; R: Pearson coefficient. 
                           DASS-21      DASS-21    DASS-21          PSS-10
                               stress             anxiety      depression
Median (IQR)   16 (10-21.5)    5 (2.5-11.5)    6 (4-13.5)     16.5 (11.25-21)
R                            0.0217            –0.033          0.2424             0.1853
COVID No-COVID analysis. HCWs population was
subsequently divided according to COVID/No-COVID
hospital. As mentioned before in Table I, Piacenza-Parma
Hospital and Roma Tor Vergata Breast Cancer Center were
designated as COVID hospitals by the National Health
system in low prevalence and high prevalence areas,
respectively. Campus Bio-Medico University Hospital and
Modena University Hospital were used as control for this
analysis in low and high prevalence areas, respectively. 
Consequently, 29 (63%) questionnaires were collected from
COVID hospital and 17 (23%) were submitted from No-
COVID hospital. As displayed in Table VI, the analysis did
not identify any significant differences in the distribution of
DASS-21 subset of anxiety and depression and PSS score in
the COVID hospital compared to No-COVID hospital
(p>0.05). Conversely, statistically significant distribution was
found in the median DASS-21 score (p=0.043). However,
independent-samples Mann-Whitney U-test failed to find
statistically significant distribution between the two cohorts
(p>0.05) in regard to the DASS-21 stress score according to
groups (normal, mild, moderate, severe, extremely severe). 
COVID Hospital HCWs exhibited lower mean value of
reported stress when compared with No-COVID hospital
HCWs (22.03 vs. 26.00). This result was confirmed when the
PSS scores were classified as ordinal values. Greater rate of
high perceived stress was observed in the No-COVID sample
(No-COVID: 17.65% vs. COVID: 6.90%). Despite these
data, DASS-21 stress score (COVID: 17.24% vs. No-COVID
5.88%) was found to be as expected from the distribution of
the values, as mentioned before. The same result was
reported for DASS-21 anxiety (COVID: 13.79% vs. No-
COVID 11.76%) and DASS-21 depression score showed
similar results (COVID: 17.24% vs. No-COVID 17.65%).
All Distributions of DASS-21 stress, anxiety, depression and
PSS scores are reported in Figure 1. 
District prevalence. Due to the characteristic pattern of
COVID outbreak in Italy, we divided the HCWs according
to COVID-19 DP. Following the first 2 imported cases in
Rome, the first Italian COVID-19 transmission was reported
in Lombardy and higher prevalence was reported in the
North of Italy (Lombardy, Veneto and Emilia Romagna) (3).
Accordingly, Campus Bio-Medico University Hospital and
Tor Vergata University Hospital were classified as low
prevalence (low prevalence district) and Modena University
Hospital together with Piacenza Parma Hospital as high
prevalence (high prevalence district). Distribution of HCWs
according to DP resulted in 19 (43.30%) HCWs in the high
prevalence district while 17 (56.70%) questionnaires were
collected from the control group (low prevalence group).
Table VII displays the median scores and category
distribution for DASS-21 stress, anxiety and PSS scores
according to DP. According to our data, DASS-21 stress,
anxiety and depression score distribution wasn’t influenced
by COVID-19 prevalence in the Hospital district (p>0.05).
Although the median value of the PSS score was higher in
the high prevalence district, a statistically significant
difference in terms of distribution was not found between the
groups. However, a high rate of severe and extremely severe
scores was found in DASS-21 subsets (DASS-21 stress
21.05% vs. 7.4%; DASS-21 anxiety 26.32% vs. 3.7%;
DASS-21 depression 26.32% vs. 11.11%). The same
disposition was found for PSS scores of medium and high
perceived stress (73.86% vs. 62.96%). Figure 2 summarizes
DSS-21 and PSS-10 distributions according to district
prevalence (High vs. Low). 
Discussion
Breast Cancer guidelines determined a shift in the clinical
and health organization in the last 20 years, resulting in
better clinical outcomes for patients (18-20). In order to
provide the best clinical outcome, all surgeons and
physicians involved in breast cancer care spent more than
in vivo 34: 1685-1694 (2020)
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Table IV. DAS-21 score and PSS score according to Sex. All values are
express as medians and IQRs (interquartile ranges). All categorical
data are expressed as numbers and percentages. p-Values are obtained
with T-test for continuous variable and with Independent-Samples
Mann-Whitney U-Test for ordinal data.
                                              Male (n=16)       Female (n=30)      p-Value
DASS-21 stress                    16 [10.5;20]           14 [10;22]           0.773
DASS-21 anxiety                    8 [2;12.5]                4 [4;8]               0.370
DASS-21 depression                7 [2;13]               6 [4.5;13]            0.999
PSS-10                                 15 [10.5;21.5]    17 [12.25;20.75]      0.873
DASS-21 Stress
  Normal                                   4 (25%)                9 (30%)             0.808
  Mild                                    7 (43.75%)          11 (36.77%)              
  Moderate                              2 (12.5%)            7 (23.33%)               
  Severe                                  1 (6.25%)             1 (3.33%)                
  Extremely severe                 2 (12.5%)             2 (6.67%)                
DASS-21 anxiety
  Normal                                   8 (50%)            20 (66.67%)          0.700
  Mild                                        0 (0%)              4 (13.33%)               
  Moderate                             5 (31.25%)            2 (6.67%)                
  Severe                                  1 (6.25%)               0 (0%)                   
  Extremely severe                 2 (12.5%)              3 (10%)                  
DASS-21 depression
  Normal                               11 (68.75%)           18 (60%)            0.576
  Mild                                    3 (18.75%)            2 (6.67%)                
  Moderate                                 0 (0%)              4 (13.33%)               
  Severe                                    0 (0%)              4 (13.33%)               
  Extremely severe                 2 (12.5%)             2 (6.67%)                
PSS                                                                                                        
  Low perceived stress          6 (37.5%)              9 (30%)             0.927
  Medium perceived stress    7 (43.75%)          19 (63.33%)              
  High perceived stress        3 (18.75%)            2 (6.67%)                
50% of their working hours with minimum caseload (20, 21).
Breast Cancer treatment requires a profound knowledge of
cancer behavior in order to reduce the risk of tumors
progression (22-24). On the other hand, a surgical plan
should be seen as an opportunity for breast remodeling that
may enhance the woman’s appearance (25-30). For these
reasons, BCC HCWs’ workload may be assumed as
homogenous in terms of effect by perceived stress, anxiety
and depression. 
Resource reallocation and risk of cross infection are two
of the many issues that BCC HCWs are facing during the
COVID-19 outbreak. Today, having no reliable data
regarding the end of the epidemic, the idea of postponing all
treatments until the end of the outbreak is not feasible for
cancer patients. Therefore, several guidelines have been
published in order reduce the detrimental effect of COVID-
19 outbreak (2, 7, 8, 31-33). Triage of urgent clinical cases,
awake and fast track surgery could increase the number of
treated patients, reducing hospitalizations as well as the risk
of cross-infection during the COVID-19 era (8, 34-38).
Breast oncological treatment was only partially impaired by
the COVID-19 outbreak and breast specialists try to provide
the best cancer treatment for a higher number of patients (2,
7, 8, 35, 39). Hence, breast cancer specialists could provide
a good model for understanding how the COVID-19
outbreak could influence health well-being among the low
risk HCWs population. 
In our study, age did not show any correlation with DASS-
21 stress, anxiety, depression and PSS scores (R: 0.0217, -
0.033, 0.2424, 0.1853, respectively), as already demonstrated
by Styra et al. in SARS outbreak (10).
In contrast to earlier findings determining that nurses are
at higher risk of emotional distress in tertiary care hospital
during outbreak (10, 12), our data demonstrated no
difference in terms of DASS-21 and PSS scores between
the different HCWs (physician, surgeon and nurse) in low
risk environment. Although our results seem to contradict
the data from Lai et al. and Styra et al., we underline that
both works included HCWs directly exposed to index
outbreak (10, 12). As stated before, our population
consisted of Breast Cancer Center workers yet no one in
the cohort assisted in any circumstances COVID-19
symptomatic patients. Thus, were considered at lower risk
for COVID exposure. 
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Table V. DAS-21 score, PSS score and work. All values are express as medians and IQRs (interquartile ranges). All categorical data are expressed
as numbers, p-Values are obtained with One-way ANOVA for continuous variable and with Independent-Samples Kruskal-Wallis test for ordinal
data.
                                                                      Physician (n=17)                            Surgeon (n=18)                         Nurse (n=10)                            p-Value
DASS-21 stress                                              17.5 [9.5;20.5]                                  17 [11;22]                              15 [10;34.5]                               0.307
DASS-21 anxiety                                              14[12;17.5]                                       5 [4;9.5]                                 5 [2.5;18]                                 0.602
DASS-21 depression                                           5 [2;11]                                          6 [4;10]                                  6 [4;32.5]                                 0.247
PSS                                                                 16 [12.25;19.5]                                17.5 [12;14]                              18 [14;25]                                0.348
DASS-21 stress
  Normal                                                            5 (29.45%)                                     4 (22.22%)                                4 (40%)                                  0.711
  Mild                                                                6 (35.30%)                                    10 (55.56%)                               2 (20%)                                       
  Moderate                                                         5 (29.42%)                                     2 (11.12%)                                 1(10%)                                        
  Severe                                                              1 (5.83%)                                       1 (5.56%)                                   0 (0%)                                        
  Extremely severe                                               0 (0%)                                         1 (5.56%)                                   3 (3%)                                        
DASS-21 anxiety
  Normal                                                           10 (58.82%)                                   12 (66.67%)                               6 (60%)                                  0.966
  Mild                                                                2 (11.76%)                                      1 (5.56%)                                   0 (0%)                                        
  Moderate                                                         5 (29.42%)                                     2 (11.12%)                                 1 (10%)                                       
  Severe                                                                0 (0%)                                         1 (5.56%)                                   0 (0%)                                        
  Extremely severe                                               0 (0%)                                        2 (11.12%)                                 2 (20%)                                       
DASS-21 depression
  Normal                                                           11 (64.70%)                                   10 (55.56%)                               7 (70%)                                  0.735
  Mild                                                                2 (11.76%)                                     3 (16.67%)                                  0 (0%)                                        
  Moderate                                                          1 (5.88%)                                      2 (11.12%)                                 2 (20%)                                       
  Severe                                                             2 (11.76%)                                     2 (11.12%)                                  0 (0%)                                        
  Extremely severe                                             1 (5.88%)                                       1 (5.56%)                                  1 (10%)                                       
PSS                                                                                                                                                                                                                                   
  Low perceived stress                                             6                                                     6                                         2 (20%)                                       
  Medium perceived stress                              10 (58.82%)                                   10 (55.56%)                               6 (60%)                                       
  High perceived stress                                     1 (5.88%)                                      2 (11.12%)                                 2 (20%)                                       
Neither sex among our population seemed to have an
impact on the distribution of DAS-21 and PSS scores’ higher
values. In our cohort, women experienced median lower
value of DASS-21 and higher value of PSS-10, without
reaching statistical significance. These data are also in
contrast with previous evidence which included partially or
totally exposed COVID-19 or SARS HCWs (10, 12), but are
in line with data from Goulia et al. during the A/H1N1
pandemic in a general hospital (9).
During the COVID-19 outbreak, the NHS reallocation of
resources toward COVID-19 patients resulted in reduced
availability of facilities, and even operatory theatres were
transformed into Intensive Care Units (1, 2, 8). Moreover,
the Health system planned the creation of COVID hospitals,
totally or partially dedicated to treatment of COVID-19
patients (40). Due to the scarcity of facilities and the fear of
cross-infection, we hypothesized that low risk HCWs could
suffer in terms of psychosocial well-being when compared
to no-COVID HCWs. Despite higher value of DASS-21
anxiety, no statistically significant distribution was found
between the two populations and higher values of DASS-21
depression and PSS score were found in No-COVID HCWs.
Interestingly, DASS-21 stress score values demonstrated a
statistically significant distribution (p=0.043) between
COVID and No-COVID hospital, yet no difference was
found when populations were grouped according to ordinal
variables (normal, mild, moderate, severe, extremely severe). 
Similar results were obtained when the population was
divided according to DP. Following two imported cases in
Rome, the COVID-19 Italian outbreak emerged mainly in
the northern region, determining a relevant difference in
terms of cases and fatality rate across the country (3). In
order to assess the impact of prevalence differences on
psychosocial well-being, we divided our cohort according to
the number of cases in the hospital district. High prevalence
district HCWs experienced higher median value of DAS-21
in vivo 34: 1685-1694 (2020)
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Table VI. DAS-21 score and PSS score according to COVID Hospital/No-
COVID Hospital. All values are expressed as medians and IQRs
(interquartile ranges). All categorical data are expressed as numbers and
percentages. p-Values were obtained with t-test for continuous variable
and with Independent-Samples Mann-Whitney U-test for ordinal data.
                                                  COVID             No-COVID         p-Value
                                                  hospital                hospital
                                                   (n=29)                  (n=17)
DASS-21 stress                      18 [12;24]            14 [10;16]           0.043
DASS-21 anxiety                     6 [4;10]                4 [2;12]             0.531
DASS-21 depression                6 [4;20]                8 [4;12]             0.358
PSS-10                                    16 [11;19]            17 [13;22]           0.278
DASS-21 stress
  Normal                                7 (24.14%)           6 (35.29%)           0.087
  Mild                                    9 (31.03%)           9 (52.94%)               
  Moderate                             8 (27.59%)            1 (5.88%)                
  Severe                                  2 (6.90%)               0 (0%)                   
  Extremely severe                3 (10.34%)            1 (5.88%)                
DASS-21 anxiety
  Normal                               17 (58.62%)         11 (64,70%)          0.697
  Mild                                    3 (10.34%)            1 (5.88%)                
  Moderate                             5 (17.24%)           3 (17.65%)               
  Severe                                    0 (0%)               1 (5.88%)                
  Extremely severe                4 (13.79%)            1 (5.88%)                
DASS-21 depression
  Normal                               19 (65.51%)         10 (58.82%)          0.654
  Mild                                    3 (10.34%)           2 (11.76%)               
  Moderate                              2 (6.90%)            2 (11.76%)               
  Severe                                 3 (10.34%)            1 (5.88%)                
  Extremely severe                 2 (6.90%)            2 (11.76%)               
PSS                                                                                                        
  Low perceived stress        10 (34.48%)          5 (29.41%)           0.456
  Medium perceived stress   17 (58.62%)          9 (52,94%)               
  High perceived stress         2 (6.90%)            3 (17.65%)               
Bold value indicates statistical significance.
Table VII. DAS-21 score and PSS score according to District
Prevalence. All values are express as medians and IQRs (interquartile
ranges). All categorical data are expressed as numbers and
percentages. p-Values were obtained with t-test for continuous variable
and with independent-samples Mann-Whitney U-test for ordinal data. 
                                                    High                     Low              p-Value
                                               prevalence           prevalence
                                                  district                 district
                                                   (n=19)                  (n=27)
DASS-21 stress                      14 [10;21]            16 [11;21]            0.723
DASS-21 anxiety                     6 [4;14]                 4 [2;9]               0.113
DASS-21 depression                6 [6;20]                6 [4;10]             0.123
PSS-10                                  17 [13;21.5]            16 [9;20]            0.139
DASS-21 stress
  Normal                                6 (31.58%)           7 (25.93%)           1.000
  Mild                                    7 (36.84%)          11 (40.74%)              
  Moderate                             2 (10.53%)           7 (25.93%)               
  Severe                                  1 (5.26%)             1 (3,70%)                
  Extremely severe                3 (15.79%)            1 (7.70%)                
DASS-21 anxiety
  Normal                               11 (57.89%)          17 (3.70%)           0.394
  Mild                                     1 (5.26%)            3 (11.11%)               
  Moderate                             2 (10.53%)           6 (22.22%)               
  Severe                                  1 (5.26%)               0 (0%)                   
  Extremely severe                4 (21.05%)            1 (3.70%)                
DASS-21 depression
  Normal                               11 (57.89%)          18 (3.70%)           0.387
  Mild                                    2 (10.53%)           3 (11.11%)               
  Moderate                              1 (5.26%)            3 (11.11%)               
  Severe                                 2 (10.53%)            2 (7.41%)                
  Extremely severe                3 (15.80%)            1 (3.70%)                
PSS                                                                                                        
  Low perceived stress         5 (26.31%)          10 (37.04%)          0.170
  Medium perceived stress   10 (52.63%)         16 (59.23%)              
  High perceived stress         4 (5.26%)             1 (3.70%)                
stress, anxiety, depression and PSS scores. Despite these
results, no statistically significant difference was found
between the groups (high vs. low prevalence). Furthermore,
the same result was confirmed when both cohorts were
divided according to score level: despite greater rate of
higher level of stress, anxiety and depression in the high
prevalence population, our study failed to demonstrate a
statistically significant difference between HCWs among the
different districts of prevalence in terms of psychosocial
well-being. 
In line with these data, careful measures of addressing
psychosocial well-being during an outbreak should be taken
by the hospital despite its role during a future outbreak or
the incidence of future epidemic in the hospital district. In
our opinion, these data obtained from BCC HCWs should be
considered, especially for HCWs who are at low risk of
infection. 
Our study has the limitation of the small cohort, yet
population baseline data were well matched when the
population was grouped according to COVID-hospital/not-
COVID-hospital and COVID-19 prevalence. Moreover, the
Study was designed to have 4 different certified Breast
Units. The choice of BCC was made in order to obtain data
from different facilities in terms of COVID-19 treatment
(COVID-hospital) and COVID-19 prevalence. However,
further vaster studies with a larger cohort are required for the
validation of these preliminary data. Furthermore, no data
were available for the period before the COVID-19 outbreak
and no comparison was made with this baseline period. This
limitation was mainly due to the unexpected event of the
COVID-19 outbreak. We decided not to collect retrospective
data of pre-COVID-19 era. If confirmed in larger series, our
data show that district prevalence differences do not affect
psychological well-being of low risk HCWs during the
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Figure 1. DASS-21 stress, anxiety, depression and PSS score Categories. COVID-Hospital 0: No; 1: Yes. For DASS-21 score 1: Normal, 2: Mild,
3: Moderate, 4: Severe, 5: Extremely Severe. PSS Score 1: Low Perceived Stress, 2: Medium Perceived Stress, 3: High Perceived Stress.
COVID-19 pandemic. Conversely, COVID hospital HCWs
seem to obtain a higher value of DASS-21 score when
compared with No-COVID HCWs, regardless of the
COVID-19 district prevalence. Further studies are needed in
order to address the long-term effect of COVID-19 pandemic
on HCWs, particularly among low risk HCWs. These topics
are deferred to future work. 
Our multicentric descriptive study demonstrated that
working in a COVID-19 tertiary care institution did not
affect the risk of perceived anxiety and depression symptoms
among low risk HCWs during the COVID-19 pandemic and
according to the COVID-19 prevalence. 
Despite the absence of differences in the abovementioned
data, COVID hospital HCWs experienced a statistically
significant higher value of DASS-21 anxiety score, underlining
the influence of hospital organization on HCWs’ anxiety. In our
Opinion, NHS and hospital administration should promote and
provide psychological support to HCWs despite the COVID-19
prevalence in order to reduce the epidemic impact on all HCWs.
Moreover, hospital administrations should take into special
consideration the psychological support for HCWs in COVID
Hospitals, regardless of their role in COVID management. 
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